US Plans to Approve New Sunscreen Ingredient Already Used Abroad
- Gyeonghyun Cho
- Jan 3
- 1 min read
Updated: Jan 8
Jan 3, 2026
Gyeonghyun Cho
The United States is planning to approve a new sunscreen ingredient that has already been widely used in Europe, Australia, and parts of Asia. Many health experts have long argued that American consumers have fewer sunscreen options compared to people in other countries. According to the US Food and Drug Administration (FDA), sunscreens sold in the US may soon be allowed to contain bemotrizinol, a chemical that provides broad-spectrum protection against harmful ultraviolet (UV) rays.
Experts explained that bemotrizinol offers stronger protection against both UVA and UVB rays than many sunscreen ingredients currently approved in the US. These UV rays are known to cause skin cancer and premature skin aging. Researchers also noted that better UV protection could help reduce long-term skin damage, especially for people with frequent sun exposure.
FDA Commissioner Dr. Marty Makary said the US has moved too slowly in approving new sunscreen technologies compared to other countries. “We are not saying current sunscreens are unsafe,” he explained. “However, Americans deserve timely access to safe and effective products that are already available abroad.” Health experts continue to emphasize that regular sunscreen use, along with protective clothing and hats, is essential for preventing skin cancer.
